Flowonix Now Can Market Prometra II Pump in U.S. for Use with Intrathecal Baclofen
The U.S. Food and Drug Administration (FDA) has given medical device company Flowonix approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen to treat severe spasticity in diseases, including cerebral palsy (CP). The device was introduced to the U.S. market…